Long Island CRPS
Lawyer

Legal Analysis

How Car Accidents on Long Island Cause CRPS

Complex Regional Pain Syndrome (CRPS) — formerly called Reflex Sympathetic Dystrophy (RSD) — is a chronic neurological pain condition that develops after a triggering injury and produces pain that is disproportionate in severity and duration to what the original injury would typically cause. It is the nervous system gone wrong: instead of resolving after the tissue injury heals, the pain signaling pathway remains activated, amplified, and self-sustaining. The result is burning, lancinating pain, extreme sensitivity to light touch (allodynia), skin color and temperature changes, swelling, and over time, motor dysfunction, dystonia, and trophic changes in the skin, nails, and hair of the affected extremity.

Car accidents on Long Island — on the LIE, the Northern State Parkway, Sunrise Highway, Jericho Turnpike, and the dense intersection grid of Nassau and Suffolk County — trigger CRPS through several distinct mechanisms. Fractures of extremity bones are the most common precipitating injury: a tibial fracture, distal radius fracture, wrist fracture, or ankle fracture sustained in a collision may trigger CRPS Type I as the fracture heals, typically within 4 to 12 weeks of the initial injury. The exact mechanism by which a fracture triggers CRPS is incompletely understood, but involves both peripheral sensitization (inflammatory mediators at the injury site) and central sensitization (upregulation of pain signaling pathways in the spinal cord and brain). Roughly 1 to 5 percent of significant limb fractures progress to CRPS.

Nerve injuries from car accident trauma produce CRPS Type II (causalgia). When a peripheral nerve is damaged — the radial nerve in a forearm injury, the peroneal nerve in a knee injury, the median nerve in a wrist fracture — the nerve may generate spontaneous, ectopic discharge that produces constant burning pain in its distribution. Unlike CRPS Type I, which develops without identifiable nerve damage, Type II requires confirmation of the nerve injury through electrodiagnostic testing (nerve conduction study and electromyography). The distinction matters legally and medically: Type II cases involve a documentable nerve injury that strengthens the objective evidence foundation of the claim.

Surgical complications from procedures performed to treat accident injuries are another recognized trigger. A patient who undergoes ORIF for a distal radius fracture caused by a head-on collision may develop CRPS in the weeks following surgery — not from the surgery itself, but because the surgical trauma exacerbates the sensitization process already initiated by the fracture. The at-fault driver remains liable for CRPS that develops as a foreseeable consequence of surgery necessitated by the accident, under the eggshell plaintiff doctrine and the principle that a tortfeasor is liable for all foreseeable consequences of the original negligent act.

For a comprehensive discussion of car accident injury mechanisms and liability on Long Island, see our car accident lawyer page.

Budapest Criteria: Diagnosing CRPS for New York Litigation

The Budapest Criteria are the internationally accepted diagnostic standard for CRPS, developed at a consensus conference in Budapest in 2003 and subsequently validated in large clinical studies. They replaced the older IASP criteria and are now required for CRPS diagnosis in both clinical practice and litigation. Understanding the Budapest Criteria is essential for CRPS litigation because they define the clinical threshold the plaintiff must meet and the defense will attempt to contest.

The Budapest Criteria require the presence of continuing pain disproportionate to the inciting event, plus symptoms (reported by the patient) in at least three of the following four categories, and signs (observed by the clinician) in at least two of the four categories:

Sensory: Hyperesthesia (increased sensitivity to sensory stimulation) and/or allodynia (pain from normally non-painful stimuli such as light touch, clothing contact, air movement). Allodynia is the hallmark symptom of CRPS and one of the most disabling: a patient with severe allodynia cannot tolerate the touch of a bedsheet on the affected extremity.

Vasomotor: Temperature asymmetry (the affected extremity is measurably warmer or cooler than the contralateral side) and/or skin color changes (mottling, erythema, cyanosis, or pallor of the affected extremity compared to the unaffected side). Vasomotor changes reflect dysregulation of sympathetic nervous system control of blood vessel tone and are directly measurable with infrared thermography — a temperature asymmetry of 1°C or greater is clinically significant.

Sudomotor/edema: Edema (swelling of the affected extremity) and/or sweating changes (the affected limb sweats more or less than the contralateral side). Sudomotor abnormality reflects dysregulation of sympathetic nervous system control of sweat gland function and is measurable with quantitative sudomotor axon reflex testing (QSART) or thermoregulatory sweat testing.

Motor/trophic: Decreased range of motion, weakness, tremor, or dystonia of the affected extremity (motor changes); and/or trophic changes to the skin (shiny, atrophic skin), nails (brittle, ridged nails), or hair (increased or decreased hair growth) of the affected limb (trophic changes). In chronic CRPS, trophic and motor changes are often the most visible and most objective clinical findings.

In New York litigation, the Budapest Criteria diagnosis is the foundation of the serious injury threshold argument. Under Toure v. Avis Rent A Car System, 98 N.Y.2d 345 (2002), plaintiffs claiming significant limitation or permanent consequential limitation must present objective medical evidence. For CRPS, the required objective evidence consists of contemporaneous documentation of Budapest Criteria signs by the treating pain management specialist at multiple examinations, supplemented by the objective testing modalities described in FAQ item 2. The treating pain management specialist — not a retained litigation expert — is the primary and most credible witness on diagnosis.

Satisfying §5102(d): CRPS and the Serious Injury Threshold

New York Insurance Law §5102(d) requires that a plaintiff in a car accident case prove a "serious injury" as a threshold to recover non-economic damages such as pain and suffering. CRPS does not fall within the "fracture" category (unless the underlying precipitating injury was itself a fracture, which satisfies the fracture category independently). CRPS is proven under the "significant limitation of use of a body function or system" or the "permanent consequential limitation of use of a body organ or member" categories.

Significant limitation of use of a body function or system: CRPS produces significant limitation of the affected extremity — restricted range of motion, inability to bear weight, inability to use the hand for grip, writing, or fine motor tasks — that constitutes a significant limitation of a body function or system. Under Toure, this must be proven with objective evidence. The Budapest Criteria documentation, combined with thermographic and bone scan findings and the treating specialist's contemporaneous records of functional limitation at each visit, provides the objective evidence required to satisfy this category and survive a summary judgment motion.

Permanent consequential limitation: For CRPS cases that have progressed to the chronic phase — typically defined as persisting beyond 6 months from the triggering injury — the treating specialist's opinion that the condition is permanent and produces a consequential limitation of the affected extremity or body system satisfies this category. The word "consequential" requires that the limitation be significant enough to affect the plaintiff's ability to perform the activities of daily life and work duties, not merely occasional or trivial discomfort.

90/180-day category: For plaintiffs whose CRPS developed acutely after the accident and who were prevented from performing substantially all of their usual daily activities for at least 90 of the first 180 days following the accident, the 90/180 category provides an alternative threshold route. This category is particularly relevant where the CRPS is severe and the treating specialist documented significant functional restriction during the acute phase. Documenting the 90/180 category requires medical records showing the nature and duration of activity restrictions prescribed by the treating specialist, combined with the plaintiff's own testimony about specific daily activities that were prevented.

CRPS Treatment Protocols and Life Care Plan Damages

CRPS treatment is a staged, multimodal process. Understanding the treatment hierarchy is essential to understanding where case value comes from: the more invasive and permanent the required treatment, the larger the life care plan projection and the higher the ultimate case value.

Conservative treatment: The first-line approach involves desensitization physical therapy (graded exposure to tactile stimulation to reduce allodynia), mirror therapy (visual feedback to address central sensitization contributing to motor dysfunction), and calmare therapy (scrambler therapy using surface electrodes to deliver non-painful sensory information to the nervous system). These modalities are low-cost individually, but if pursued over months or years, their cumulative cost is documented in the life care plan.

Sympathetic nerve blocks: When conservative treatment fails to achieve adequate pain control, pain management specialists proceed to sympathetic nerve blockade. For upper extremity CRPS, stellate ganglion blocks are performed; for lower extremity CRPS, lumbar sympathetic blocks are used. Each block is performed under fluoroscopic guidance and costs approximately $800 to $1,500. Blocks are typically administered in series of 4 to 6, with repeat series if the condition recurs. A patient who requires two series per year over a 20-year period will incur $96,000 to $360,000 in sympathetic block costs alone, all of which is documented in the life care plan.

Ketamine infusion: For moderate to severe CRPS that is refractory to sympathetic blocks, ketamine infusion — an NMDA receptor antagonist that interrupts central sensitization — is a recognized treatment protocol. Outpatient infusion sessions cost $2,000 to $5,000 each; inpatient five-day ketamine protocols at specialized centers cost $25,000 to $60,000 per admission. For a plaintiff who requires annual inpatient ketamine protocols over a 25-year life expectancy, this component alone adds $625,000 to $1.5M to the life care plan.

Spinal cord stimulator (SCS): SCS implantation is the most significant and permanent intervention available for refractory CRPS. A temporary trial electrode is first placed epidurally to confirm adequate pain relief; if the trial is successful (typically defined as 50% or greater pain reduction), a permanent pulse generator is implanted under the skin, usually in the flank or buttock. The trial and permanent implantation procedure costs $30,000 to $60,000 in total. The pulse generator battery requires replacement every 5 to 7 years at a cost of $15,000 to $25,000 per replacement. For a 35-year-old plaintiff with a 45-year remaining life expectancy, SCS battery replacements alone require 7 to 9 replacements over their lifetime, at a projected total cost of $105,000 to $225,000, or more with medical cost inflation. When combined with ongoing nerve blocks, ketamine infusions, physical therapy, and medication management, the life care plan for a young CRPS plaintiff with SCS implantation regularly projects $500,000 to $1.6M in future costs.

A certified life care planner (CLCP) prepares the life care plan document and testifies at trial or in deposition about the projected future costs, their medical necessity, and their basis in the treating specialist's documented treatment plan. The life care planner works in conjunction with the treating pain management specialist; their plan is only as strong as the underlying treating records that support it. This is why consistent treatment compliance and comprehensive medical documentation from the earliest stages of CRPS are essential.

How Insurers Attack CRPS Claims and How We Defeat Them

CRPS is the injury type that insurance carriers and their defense teams fight most aggressively, because the condition is inherently difficult to objectively verify and because the life care plan damages in severe cases are enormous. Understanding the defense playbook is essential to building a case that survives it.

Budapest Criteria challenge: The defense IME neurologist will dispute whether the Budapest Criteria are genuinely satisfied, arguing that the documented signs and symptoms do not meet the clinical threshold or that they were reported by the plaintiff rather than independently observed by the treating specialist. The response is meticulous treating records that separately document observed signs (vasomotor and trophic changes seen by the clinician) versus reported symptoms (allodynia and pain level reported by the plaintiff).

Thermography Frye challenge: Defense attorneys routinely challenge thermography under the Frye standard, arguing that infrared thermal imaging has not achieved general acceptance in the relevant scientific community as a diagnostic tool for CRPS. The current weight of New York authority supports thermographic admissibility when performed on properly calibrated equipment in a controlled environment by a certified thermographer, with the results interpreted in conjunction with clinical findings rather than in isolation. Preparing for a Frye hearing on thermographic evidence requires a thermographer who can testify to the methodology, the equipment standards (FLIR-calibrated cameras, controlled room temperature protocol), and the published literature supporting the technique.

Surveillance: Defense investigators are deployed in virtually every CRPS case with significant life care plan damages. Video showing the plaintiff driving, shopping, carrying bags, or engaging in recreational activities that are allegedly inconsistent with the claimed disability is used at deposition and trial to impeach. The response requires careful preparation of the plaintiff about what they can and cannot do, accurate daily activity logs, and a treating specialist who has counseled the plaintiff about activity limitations and documented what activities are restricted.

Gap-in-treatment defense: Missed appointments, delays in scheduling nerve blocks, or periods without treatment are characterized as evidence that the condition is not as debilitating as claimed. CRPS patients frequently miss appointments because of flare-ups, transportation difficulties caused by the disability itself, or insurance authorization delays for high-cost procedures. Every gap in treatment must be explained in the medical records and in the plaintiff's own testimony.

Causation challenge: The defense will argue that the plaintiff's chronic pain is not CRPS caused by the accident but rather a pre-existing pain amplification disorder, fibromyalgia, or psychological condition that predated the crash. A treating pain management specialist with a clear, well-documented causation opinion — linking the Budapest Criteria findings to the accident mechanism, excluding other causes, and explaining why CRPS developed from this specific injury — is the essential response. For cases with a documented psychological component, a neuropsychologist who addresses the psychological dimension professionally, rather than leaving it for the defense to characterize as fabrication, is critical. For a comprehensive overview of how we build catastrophic injury cases, see our car accident lawyer page.